Dr Jens-Ulrich Stegmann | Vice President Head Clinical Safety And Pharmacovigilance
G.S.K Biologicals

Dr Jens-Ulrich Stegmann, Vice President Head Clinical Safety And Pharmacovigilance, G.S.K Biologicals

After completing training as registered male nurse Jens-Ulrich Stegmann studied medicine and completed his M.D. degree from the University of Essen, Germany with a focus on anesthesiology while he did his Internships in Germany and South-Africa. His PhD in Physiology he completed at the Christian Albrechts University, Kiel, Germany
He worked as anesthesiologist at the University of D├╝sseldorf before starting in the pharmaceutical industry.
He contributed to the development of a number of centrally acting analgesics as clinical lead before he moved into Safety in 2008 having the overall responsibility for different pharmaceutical products and investigational medicines
Jens joined GSK Vaccines in 2012 as Head of Safety Evaluation and Risk Management in Safety and was appointed Deputy QPPV a year later before becoming Head of Clinical Safety and Pharmacovigilance in April 2014.

Appearances:

´╗┐

April 16 Day 2 - 10 Co-conferences @ 12:10

Panel: Does industry believe in the value of Sentinel?

April 16 Day 2 - 10 Co-conferences @ 15:10

Joint presentation: Emerging innovations in vaccine safety science, perspectives from academia and industry

last published: 18/Mar/19 16:25 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071